Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers-Reference-Cited by-同舟云学术

Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers

Published:2019-12-14 Issue:3 Volume:59 Page:298-301
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Jensen Lars H.¹²,Andersen Rikke Fredslund²,Byriel Lene²,Fernebro Eva³,Jakobsen Anders¹²,Lindebjerg Jan¹²,Nottelmann Lise²,Ploen John²,Hansen Torben F.¹²

Affiliation:

1. Vejle University Hospital and University of Southern Denmark, Vejle, Denmark;

2. Departments of Biochemistry, Gentics, Oncology and Pathology, Vejle University Hospital, Vejle, Denmark;

3. Department of Oncology, Växjö Hospital, Växjö, Sweden

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2019.1701201

Reference20 articles.

1. Incidence Rates of Intra- and Extrahepatic Cholangiocarcinomas in Denmark From 1978 Through 2002

2. Systemic Therapy for Biliary Tract Cancers

3. KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

4. Wild-TypeKRASIs Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

5. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer;Cancers;2023-02-07

2. Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial;BMJ Open;2023-02

3. Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers;International Journal of Medical Sciences;2023

4. The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab;Cancers;2022-09-22